A detailed history of Trust Point Inc. transactions in Amgen Inc stock. As of the latest transaction made, Trust Point Inc. holds 2,183 shares of AMGN stock, worth $702,511. This represents 0.05% of its overall portfolio holdings.

Number of Shares
2,183
Previous 2,235 2.33%
Holding current value
$702,511
Previous $698 Million 0.74%
% of portfolio
0.05%
Previous 0.06%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 17, 2024

SELL
$309.38 - $337.38 $16,087 - $17,543
-52 Reduced 2.33%
2,183 $703 Million
Q2 2024

Jul 24, 2024

SELL
$262.75 - $319.31 $4,992 - $6,066
-19 Reduced 0.84%
2,235 $698 Million
Q1 2024

Apr 19, 2024

SELL
$268.87 - $324.56 $384,752 - $464,445
-1,431 Reduced 38.83%
2,254 $641 Million
Q4 2023

Jan 23, 2024

BUY
$255.7 - $288.46 $942,254 - $1.06 Million
3,685 New
3,685 $1.06 Billion

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $172B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Trust Point Inc. Portfolio

Follow Trust Point Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Trust Point Inc., based on Form 13F filings with the SEC.

News

Stay updated on Trust Point Inc. with notifications on news.